100
Participants
Start Date
July 17, 2025
Primary Completion Date
December 9, 2026
Study Completion Date
September 6, 2028
AZD0901
AZD0901 will be administered as an IV infusion.
Rilvegostomig
Rilvegostomig will be administered as an IV infusion.
Trastuzumab Deruxtecan (T-DXd)
T-DXd will be administered as an IV infusion.
Capecitabine
Capecitabine (Fluoropyrimidine) will be administered orally as chemotherapy standard of care.
5-Fluorouracil (5-FU)
5-FU (Fluoropyrimidine) will be administered as an IV infusion as chemotherapy standard of care.
FLOT Chemotherapy
FLOT (5-FU, leucovorin, oxaliplatin, and docetaxel) Chemotherapy will be administered as an IV infusion.
NOT_YET_RECRUITING
Research Site, Tainan City
NOT_YET_RECRUITING
Research Site, New York
NOT_YET_RECRUITING
Research Site, New York
NOT_YET_RECRUITING
Research Site, Taipei
NOT_YET_RECRUITING
Research Site, Pittsburgh
NOT_YET_RECRUITING
Research Site, Newark
NOT_YET_RECRUITING
Research Site, Washington D.C.
NOT_YET_RECRUITING
Research Site, Rozzano
NOT_YET_RECRUITING
Research Site, Milan
NOT_YET_RECRUITING
Research Site, Milan
NOT_YET_RECRUITING
Research Site, Milan
NOT_YET_RECRUITING
Research Site, Erzurum
NOT_YET_RECRUITING
Research Site, Madrid
NOT_YET_RECRUITING
Research Site, Málaga
NOT_YET_RECRUITING
Research Site, Ourense
NOT_YET_RECRUITING
Research Site, Oviedo
NOT_YET_RECRUITING
Research Site, Udine
NOT_YET_RECRUITING
Research Site, Taoyuan District
NOT_YET_RECRUITING
Research Site, Fatih-Istanbul
NOT_YET_RECRUITING
Research Site, Istanbul
NOT_YET_RECRUITING
Research Site, Vicenza
NOT_YET_RECRUITING
Research Site, Santander
NOT_YET_RECRUITING
Research Site, Modena
NOT_YET_RECRUITING
Research Site, Valencia
RECRUITING
Research Site, North Shores
NOT_YET_RECRUITING
Research Site, Florence
NOT_YET_RECRUITING
Research Site, Adapazarı
NOT_YET_RECRUITING
Research Site, Pisa
NOT_YET_RECRUITING
Research Site, Fairway
NOT_YET_RECRUITING
Research Site, Kaohsiung City
RECRUITING
Research Site, Beijing
NOT_YET_RECRUITING
Research Site, Changchun
NOT_YET_RECRUITING
Research Site, Shanghai
NOT_YET_RECRUITING
Research Site, Qingdao
NOT_YET_RECRUITING
Research Site, Hangzhou
NOT_YET_RECRUITING
Research Site, Fuzhou
NOT_YET_RECRUITING
Research Site, Chengdu
NOT_YET_RECRUITING
Research Site, Kunming
NOT_YET_RECRUITING
Research Site, Toronto
NOT_YET_RECRUITING
Research Site, Montreal
NOT_YET_RECRUITING
Research Site, Montreal
NOT_YET_RECRUITING
Research Site, Tbilisi
NOT_YET_RECRUITING
Research Site, Tbilisi
NOT_YET_RECRUITING
Research Site, Tbilisi
NOT_YET_RECRUITING
Research Site, Tbilisi
RECRUITING
Research Site, Chūōku
NOT_YET_RECRUITING
Research Site, Fukuoka
NOT_YET_RECRUITING
Research Site, Hidaka-shi
NOT_YET_RECRUITING
Research Site, Kashiwa
NOT_YET_RECRUITING
Research Site, Kitaadachi-gun
NOT_YET_RECRUITING
Research Site, Kōtoku
NOT_YET_RECRUITING
Research Site, Nagoya
NOT_YET_RECRUITING
Research Site, Osaka
NOT_YET_RECRUITING
Research Site, Osaka
NOT_YET_RECRUITING
Research Site, Suita-shi
WITHDRAWN
Research Site, Bialystok
WITHDRAWN
Research Site, Warsaw
NOT_YET_RECRUITING
Research Site, Barcelona
NOT_YET_RECRUITING
Research Site, Barcelona
NOT_YET_RECRUITING
Research Site, Elche
NOT_YET_RECRUITING
Research Site, Bristol
NOT_YET_RECRUITING
Research Site, Dundee
NOT_YET_RECRUITING
Research Site, Headington
NOT_YET_RECRUITING
Research Site, Norwich
Lead Sponsor
Collaborators (1)
Parexel
INDUSTRY
AstraZeneca
INDUSTRY